This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.
A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.
“This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design,” says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).
From 2013–2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world’s leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.
The VIC researchers aim to understand which Ebola-fighting antibodies are best—and why. The hope is that the most effective antibodies can be combined in a therapeutic “cocktail.” Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.
“Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection,” says Saphire. “We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself.”
In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies “neutralized” the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.
Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person’s immune system, helping orchestrate a better immune response to the virus.
This “immune effector” activity is featured in the team’s companion study published simultaneously in Cell Host & Microbe. “The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection,” says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.
From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.
The Latest on: Ebola
via Google News
The Latest on: Ebola
WFP to donate Ambulances for Ebola preparedness tomorrow
on February 20, 2019 at 11:34 pm
Content provided by APO Group. CNBC Africa provides content from APO Group as a service to its readers, but does not edit the articles it publishes. CNBC Africa is not responsible for the content prov... […]
WHO and Uganda Red Cross society sign agreement to strengthen Ebola screening at Points of Entry
on February 20, 2019 at 9:54 pm
Kampala, 20 February 2019:- The World Health Organization (WHO) and the Uganda Red Cross Society today signed an agreement to strengthen the screening of travellers at 25 points of entry in eight dist... […]
How the World Bank’s ‘pandemic bonds’ resisted Ebola
on February 20, 2019 at 8:00 pm
Two years ago the World Bank celebrated what it called “a momentous step” — an attempt to use the global bond markets to change the face of aid and development. The Bank had just sold its first “pande... […]
Experimental Ebola vaccine OK'd for pregnant women
on February 20, 2019 at 5:13 pm
Health officials on Feb. 20 ruled that women who are pregnant or lactating may now receive Merck's experimental Ebola vaccine in the Democratic Republic of Congo, reports STAT. Three things to know: 1 ... […]
First Person: To stop Ebola, ask the rebels to help
on February 20, 2019 at 11:28 am
The Democratic Republic of Congo is in the midst of its 10th Ebola outbreak. Since the first case was declared in the northeastern town of Beni in August 2018, almost 800 cases have been confirmed in ... […]
Ebola vaccine will be provided to women who are pregnant, marking reversal in policy
on February 20, 2019 at 11:08 am
Women who are pregnant and lactating, as well as children under the age of 1, will be offered access to an experimental Ebola vaccine in the Democratic Republic of the Congo, officials said Wednesday, ... […]
DRC Says Ebola Outbreak Under Control In Beni, Continues In Katwa, Butembo; Trial Underway To Evaluate Ebola Treatments
on February 20, 2019 at 10:56 am
“In a promising development in the former Ebola hot spot of Beni, the Democratic Republic of the Congo (DRC) [Tuesday] announced that a full Ebola incubation period — 21 days — has passed without any ... […]
Ebola outbreak 'under control' in part of eastern DR Congo
on February 20, 2019 at 5:01 am
KINSHASA, DR Congo - An Ebola epidemic that has killed more than 500 people in the eastern Democratic Republic of Congo has been brought under control in one major area, the health ministry said late ... […]
Irish aid workers braced for 'Ebola disaster' in war-torn Congo
on February 19, 2019 at 2:37 pm
Irish aid workers are bracing themselves for a potential Ebola disaster in war-torn Congo. Mark Johnson, 33, is on the ground with charity Concern as they fight to contain the fatal virus. The lawyer ... […]
via Bing News